Lionco Pharmaceutical GroupLtd's high P/S ratio is alarming ...
Lionco Pharmaceutical GroupLtd's high P/S ratio is alarming due to its falling revenue. Unless there's a significant improvement in medium-term conditions, the current share price may not be considered fair value. The company's declining revenue and high P/S ratio could negatively impact the future share price.
![](https://pubimg-10000538.picsh.myqcloud.com/202205090000017688cce53558c.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment